Institutional Ownership Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 60.1 Million shares, which have been reported (via 13F filing form) to have a value of $211 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
324,472
shares
|
$1.14 Million
0.0% of portfolio
|
Q3 2024
Added 87.79%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
318,760
shares
|
$1.12 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.29%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
283,252
shares
|
$997,047
0.0% of portfolio
|
Q3 2024
Added 73.1%
|
|
|
Iht Wealth Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
276,885
shares
|
$974,635
0.02% of portfolio
|
Q3 2024
Reduced 6.56%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
241,571
shares
|
$850,329
0.0% of portfolio
|
Q3 2024
Added 910.63%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
217,089
shares
|
$764,153
0.0% of portfolio
|
Q3 2024
Reduced 1.28%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
210,843
shares
|
$742,167
0.0% of portfolio
|
Q3 2024
Added 1317.91%
|
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
190,255
shares
|
$669,697
0.0% of portfolio
|
Q1 2024
Reduced 10.0%
|
|
|
Commonwealth Equity Services, LLC
|
Oct 18, 2024 Q3 2024 |
187,443
shares
|
$659,799
0.0% of portfolio
|
Q3 2024
Added 0.24%
|
|
|
Diversified Trust CO
|
Jan 07, 2025 Q4 2024 |
175,739
shares
|
$618,601
0.02% of portfolio
|
Q2 2024
Reduced -0.0%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
173,556
shares
|
$610,917
0.0% of portfolio
|
Q3 2024
Reduced 8.64%
|
|
|
Thompson Siegel & Walmsley LLC
|
Nov 12, 2024 Q3 2024 |
172,784
shares
|
$608,199
0.01% of portfolio
|
Q2 2024
Reduced 9.06%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
172,327
shares
|
$606,591
0.0% of portfolio
|
Q3 2024
Reduced 48.72%
|
|
|
Prem Watsa
Fairfax Financial Holdings LTD | Toronto, A6
|
Nov 14, 2024 Q3 2024 |
170,937
shares
|
$601,698
0.04% of portfolio
|
Q2 2024
Added 12.91%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
160,976
shares
|
$566,635
0.0% of portfolio
|
Q3 2024
Added 22.91%
|
|
|
Alpine Global Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
160,000
shares
|
$563,200
0.14% of portfolio
|
Q3 2024
Reduced 46.67%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
147,720
shares
|
$519,974
0.0% of portfolio
|
Q2 2024
Added 83.69%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
119,427
shares
|
$420,383
0.0% of portfolio
|
Q3 2024
Added 163.37%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Dec 19, 2024 Q3 2024 |
102,469
shares
|
$360,690
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
102,393
shares
|
$360,423
0.04% of portfolio
|
Q3 2024
Added 1.55%
|
|
|
Sg Americas Securities, LLC
|
Jan 17, 2025 Q4 2024 |
94,671
shares
|
$333,241
0.0% of portfolio
|
Q4 2024
Added 57.26%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
84,740
shares
|
$298,284
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 08, 2024 Q3 2024 |
83,108
shares
|
$292,540
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
80,420
shares
|
$283,078
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
79,915
shares
|
$281,300
0.0% of portfolio
|
Q3 2024
Added 147.83%
|